The clinical relevance of circulating tumor necrosis factor-α in acute decompensated chronic heart failure without cachexia

Chest

Volumn 110, Issue 4, 1996, Pages 992-995

  Milani, Richard V ^a,d   Mehra, Mandeep R ^a   Endres, Stefan ^c   Eigler, Andreas ^c   Cooper, E Shannon ^b   Lavie Jr , Carl J ^a   Ventura, Hector O ^a  

^a Section on Cardiology   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d NONE   (United States)

Author keywords

cytokines; heart failure; inotropes; tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CACHEXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029958555     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.992     Document Type: Article

References (16)

1. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45:491-503
2. Pagani, FD, Baker LS, Hsi C, et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992; 90:389-98
3. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92:2303-12
4. Hagewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990; 335:294-95
5. Horgan MJ, Palace GP, Everitt JE, et al. TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol 1993; 264:H1161-65
6. Stephens KE, Ishizaka A, Larick JW, et al. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis 1988; 137:1364-70
7. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-41
8. McMurray J, Abdullah I, Dargie HJ, et al. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991; 66:356-58
9. Endres S, Sinha B, Fülle HJ. Amrinone suppresses the synthesis of tumor necrosis factor in human mononuclear cells. Shock 1994; 1:377-80
10. Matsumori A, Shioi T, Yamada T, et al. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation 1994; 89:955-58
11. Manson JE, Stampfer MJ, Hennekens CH, et al. Body weight and longevity. JAMA 1987; 257:353-58
12. Blackburn GL, Harvey KB. Nutritional assessment as a routine in clinical medicine. Postgrad Med 1982; 71:46-63
13. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996; 27:1201-06
14. Tracey KJ, Lowry SF, Beutler B, et al. Cachectin/tumour necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 1986; 164:1368-73
15. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994; 105:897-904
16. Engelmann GL, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990; 265:1531-36